Illumina Challenges Ownership Rights for Patent Covering ParAllele Technology Acquired

Illumina Challenges Ownership Rights for Patent Covering ParAllele Technology Acquired by Affymetrix (Business Wire via Yahoo! Finance)
Illumina, Inc. announced today that it has made a formal filing with the United States Patent and Trademark Office requesting Interference with U.S. Patent Number 6,858,412. The ’412 patent relates to the molecular inversion probe genotyping technology of ParAllele BioScience, which was recently acquired by Affymetrix.